Vaginal atrophy

Vaginal atrophy — when tissues thin and lose moisture

Vaginal atrophy — also called vulvovaginal atrophy or VVA — describes the thinning, drying, and inflammation of vaginal tissues that often follows a sustained drop in estrogen. It's most common after menopause but can also occur during breastfeeding, after surgical menopause, or as a side effect of certain cancer treatments. Topical hydration and tissue-supportive ingredients can restore comfort even when hormone therapy isn't an option.

How to recognize it

Common symptoms of vaginal atrophy

Vaginal atrophy is more than dryness — it's a tissue change that affects multiple aspects of intimate and urinary health. Recognizing the cluster of symptoms is the first step toward addressing it.

  • Persistent vaginal dryness
  • Burning, itching, or general irritation
  • Pain during intercourse, sometimes with light bleeding after
  • Recurrent urinary tract infections
  • Urinary frequency, urgency, or burning during urination

When to seek medical care

Talk to your gynecologist if

Most symptoms of vaginal atrophy respond to non-hormonal topical care. But certain signs warrant a gynecologist's input — especially if they're new or progressing.

Any bleeding after menopause
Severe pain or pressure in the pelvic area
Signs of infection that recur or don't resolve
Symptoms unresponsive to weeks of topical care

How LibiTight helps

How LibiTight helps with vaginal atrophy

Vaginal atrophy responds particularly well to topical hyaluronic acid — one of the most-studied non-hormonal approaches in this category. LibiTight's formula combines HA with allantoin's protective barrier and chamomile's anti-inflammatory action, addressing dryness, friction discomfort, and inflammation through one daily application.

  • Hyaluronic acid restores tissue moisture and supports elasticity — directly addressing the core change of atrophy.
  • Allantoin builds a protective barrier on thinned tissue surfaces, reducing irritation and supporting comfort.
  • Chamomile soothes inflammation that often accompanies tissue thinning.
  • Non-hormonal — appropriate when estrogen therapy is contraindicated, including for women with hormone-sensitive cancer history.
Learn about the ingredientsSee how it works

Research highlights

Published research on this condition

Hyaluronic acid is among the most-studied non-hormonal interventions for vaginal atrophy. Two trials especially relevant to LibiTight's formula:

Hyaluronic Acid

Hyaluronic acid in postmenopausal vaginal atrophy

Hyaluronic acid produced significant improvements in moisture and tissue elasticity, with reductions in atrophy symptoms. No significant adverse effects were reported.

Hyaluronic Acid

Topical hyaluronic acid for vulvovaginal atrophy

Eight weeks of topical hyaluronic acid application improved vaginal health and tissue elasticity. Participants reported enhanced hydration with no adverse effects.

Next step

What to do now

Vaginal atrophy is a real, treatable tissue change — not something to accept silently. Three paths forward:

  • Find a pharmacy

    Locate pharmacies stocking LibiTight nearby.

    Where to buy

  • Ask us directly

    Questions about whether LibiTight fits your circumstances? Reach us directly.

    Open WhatsApp